HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 11, November 2017 – Paediatric Illnesses       » Breakthrough new rice variety announced in Northern China       » Ebola vaccine approved in China       » Study reveals anti-cancer properties of a fungus used in traditional medicine       » Chinese scientists create genetically modified low-fat pigs       » China, Brazil and Russia are riskiest markets for compliance and regulation       » Why are Korean eggs salmonella-free?      
EYE on CHINA
ICON Signs Collaboration Agreement with the Taiwan National Centre of Excellence for Clinical Trials and Research
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and the National Clinical Trials and Research Centre (NCTRC) at the National Taiwan University Hospital, have announced a collaboration agreement to enhance the set-up and management of clinical studies in Taiwan.

Under the terms of the agreement NCTRC and ICON will work together on study start-up, site feasibility, key site and investigator selection and patient recruitment. Both organizations will also work together on further enhancing the already high standards of clinical research in Taiwan.

“We are very pleased to be collaborating with the NCTRC who are at the forefront of clinical research in Taiwan,” commented Wei Ming Goh, ICON's Vice President, Asia-Pacific. “Our customers are increasingly looking to include Taiwan in their clinical programs and are expecting fast timelines for study start-up and patient recruitment. By combining the proven expertise of ICON and NCTRC in the region, we can further accelerate study timelines which will benefit our customers and also enhance the Taiwanese clinical trials industry.”

“The aim of this partnership is to accelerate new drug development and new treatments for diseases and we hope to achieve this by leveraging our respective strengths,” commented Professor Chan Wing Kai, Director of NCTRC. “We are happy to be collaborating with ICON, a leading clinical research organisation that has proven experience in both global and local clinical development programs.”

Click here for the complete issue.

NEWS CRUNCH  
news MIT Technology Review announces 2018's 10 'Innovators Under 35 Asia'
news Novogen becomes Kazia Therapeutics
news Transforming healthcare through innovation: addressing unmet healthcare needs in Asia Pacific
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Infectious Diseases
October:
A change of heart — Cardiovascular diseases
November:
Paediatric Illnesses
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy